1. United Kingdom Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Victrex plc

Victrex plc

VCT.L
Victrex plcGB flagLondon Stock Exchange
582.00
GBp
-8.00
- -
506.78MMarket Cap
Victrex plc
VCT.L
(London Stock Exchange)

Recent

price

582.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
2.29
2.59
2.62
2.63
2.98
3.1
2.96
3.39
3.8
3.34
3.06
3.59
3.92
3.53
3.41
3.41
Revenue per Share
0.65
0.85
0.86
0.86
0.95
0.98
0.97
1.16
1.29
1.07
0.63
0.84
0.88
0.71
0.2
0.32
Basic EPS, GAAP
0.88
0.68
0.47
0.47
0.38
0.55
0.67
1.18
1.39
0.67
0.51
0.98
0.4
0.04
0.59
0.57
Free Cash Flow per Basic Share
0.2
0.77
0.33
0.39
0.44
0.95
0.47
0.47
1.23
1.42
0.46
0.6
1.1
0.6
0.6
0.6
Dividend per Share
2.22
2.32
2.84
3.29
3.74
3.78
4.18
5.02
5.14
4.73
4.86
5.15
4.93
4.99
4.59
4.33
Book Value per Share
2.43
2.54
3.11
3.6
4.05
3.97
4.29
5.24
5.38
5.04
5.26
5.62
5.41
5.55
5.11
4.77
Tangible Book Value per Share
83
83
84
84
85
85
85
85
86
86
86
87
87
87
87
87
Basic Weighted Avg Shares
190
216
220
222
253
264
252
290
326
288
264
311
341
307
296
296
Sales/Revenue/Turnover
39.53
43.47
42.77
42.36
40.46
40.34
39.95
38.97
38.93
36.65
28.73
30.01
25.95
23.84
15.46
13.43
Operating Margin (%)
9
9
10
10
10
13
16
18
18
17
21
22
22
22
23
25
Depreciation Expense
54
71
72
73
80
84
82
100
111
92
54
73
76
62
17
28
Net Income, GAAP
27.9
24.42
23.92
22.94
21.91
21.52
17.75
10.36
13.25
11.75
14.65
21.3
13.91
15.86
32.48
26.33
Effective Tax Rate (%)
28.5
32.99
32.71
32.85
31.75
31.69
32.7
34.29
33.93
32.07
20.49
23.52
22.35
20.1
5.81
9.38
Profit Margin (%)
91
98
128
141
134
105
121
188
206
159
173
182
147
173
156
124
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
6
14
29
43
41
30
LT Debt
211
222
271
314
353
359
389
478
490
462
481
512
491
501
462
431
Total Equity
27
30.79
27.6
23.4
22.92
22.86
21.58
22.93
22.35
19.17
13.49
14.42
14.46
11.43
5.79
5.9
Return on Invested Capital (%)
32.76
37.77
33.4
28.34
26.99
26.18
24.41
25.44
25.41
21.77
13.01
16.49
16.65
13.24
4.22
7.44
Return on Capital (%)
32.72
37.73
33.36
28.28
26.96
26.13
24.34
25.34
25.41
21.77
13.1
16.9
17.43
14.32
4.13
7.17
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.22%
-2.01%
-6.59%
Free Cash Flow
148.66%
288.68%
-4.09%
Net Income, GAAP
-1.76%
1.93%
61.63%
Sales/Revenue/Turnover
1.71%
2.76%
0.07%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
296
2025
- -
- -
- -
- -
296
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.2
2025
- -
- -
- -
- -
0.32
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.6
2025
- -
- -
- -
- -
0.6
2026
- -
- -
- -
- -
- -
Similar Companies
Toyobo Co., Ltd. (TYOBY)
Jiangsu Innovative Ecological New Materials Limited (2116.HK)
Covestro AG (COVTY)
Jiangsu Jiuding New Material Co., Ltd. (002201.SZ)
Kaofu Chemical Corporation (4773.TWO)
Dynemic Products Limited (DYNPRO.BO)
Business
Victrex plc manufactures and sells high-performance PEEK and PAEK polymer solutions worldwide, including semi-finished and finished parts such as pipes, films, fibres, composite tapes and specialist medical components; it operates through Sustainable Solutions and Medical segments serving automotive, aerospace, energy and industrial, electronics, manufacturing and engineering, and medical markets. The company, founded in 1993 and headquartered in Thornton-Cleveleys, Lancashire, UK, focuses on brands including VICTREX PEEK polymers like 450G, APTIV films, AE 250 composites, PEEK-OPTIMA for medical devices, and VICTREX XPI for e-mobility applications; its products enable lightweighting, durability, chemical resistance and sustainability in over 40 countries with 98% of revenues from outside the UK. Recent developments include the commercial start-up of new manufacturing facilities in Panjin, China, during fiscal year 2024 to broaden PEEK grades and support regional growth; progression in mega-programmes such as Magma with a technological contract order from Petrobras to TechnipFMC in May 2025, Aerospace Composites business wins in Advanced Air Mobility, Trauma Plates regulatory submissions in China, and PEEK Knee with first US clinical trial implants; alongside a Profit Improvement Plan targeting at least £10m in annual savings by fiscal year 2027, impairment of investments in Bond 3D and Surface Generation, and maintenance of the dividend at 59.56p per share.

Company News

APIChatGPT